Clinical Trials

21 studies in Hematology in Minnesota

  1. Phase 2 Trial of MLN9708 in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib
    1. Arizona,
    2. Florida,
    3. Minnesota
  1. Prev
  2. 2
  3. 3